(Q43268967)

17 November 2017

title

Effects of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady state in healthy subjects (English)

1 reference

17 November 2017

1 reference

1 reference

1 reference

Jill Chappell

1

1 reference

17 November 2017

Jingsong He

2

1 reference

17 November 2017

Mary Pat Knadler

3

1 reference

17 November 2017

Malcolm Mitchell

4

1 reference

17 November 2017

Douglas Lee

5

1 reference

17 November 2017

Evelyn Lobo

6

1 reference

17 November 2017

publication date

30 September 2009

1 reference

The Journal of Clinical Pharmacology

17 November 2017

published in

1 reference

17 November 2017

volume

49

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

1456-1466

1 reference

Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Duloxetine: a new approach for treating stress urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Plasma protein binding displacement interactions--why are they still regarded as clinically important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Changes in plasma protein binding have little clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Selective serotonin reuptake inhibitors: measurement of effect on platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

A retrospective pooled analysis of duloxetine safety in 23,983 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Fluvoxamine interaction with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Managing oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344335

Interobserver Reproducibility and Biological Variability of the Surgicutt II Bleeding Time

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1023/A:1008861924107

Identifiers

DOI

10.1177/0091270009344335

1 reference

17 November 2017

1 reference